InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Axsome Therapeutics, Inc.

AXSM Clue Score54
United States Fiscal year ends December CIK 0001579428 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Mostly scheduled

By person

9 insiders · 117 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Herriot Tabuteau
Chief Executive Officer
—
$110.58M (20) scheduled
−$110.58M
7,229
0.0138%
$1.51M
0.0%
Mark L. Jacobson
Chief Operating Officer
—
$28.81M (13) scheduled
−$28.81M
0
0.0000%
$0.00
—
Roger Jeffs
Director
$147.35K (1)
$15.77M (11) scheduled
−$15.63M
58,367
0.1114%
$12.18M
+1,234%
Nick Pizzie
Chief Financial Officer
$351.24K (11)
$12.13M (4) scheduled
−$11.78M
43,009
0.0821%
$8.97M
+5,435%
Mark Coleman
Director
$866.84K (11)
$12.33M (12) scheduled
−$11.46M
434,245
0.8290%
$90.61M
+9.1%
Mark E Saad
Director
$192.08K (5)
$8.35M (4) scheduled
−$8.16M
11,531
0.0220%
$2.41M
+249.2%
Hunter R. Murdock
General Counsel
—
$3.65M (5) scheduled
−$3.65M
0
0.0000%
$0.00
—
Ari Maizel
Chief Commercial Officer
—
$2.75M (2) scheduled
−$2.75M
0
0.0000%
$0.00
—
Susan Mahony
Director
—
$145.02K (2) scheduled
−$145.02K
829
0.0016%
$172.97K
—